Results 181 to 190 of about 1,489,579 (226)

Clinical efficacy, safety and pharmacokinetics of novel β-lactam/β-lactamase inhibitor combinations: a systematic review. [PDF]

JAC Antimicrob Resist
Alarcia-Lacalle A, Canut-Blasco A, Solinís MÁ, Isla A, Rodríguez-Gascón A.   +4 more
europepmc   +1 more source

Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying <i>bla</i>_OXA-48. [PDF]

Microbiol Spectr
Mojica MF, Zeiser ET, Becka SA, Six DA, Moeck G, Bonomo RA, Papp-Wallace KM.   +6 more
europepmc   +1 more source

The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam. [PDF]

Antimicrob Agents Chemother
Le Terrier C, Drusin SI, Nordmann P, Pitout J, Peirano G, Vila AJ, Moreno DM, Poirel L.   +7 more
europepmc   +1 more source

Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Winkler ML, Papp-Wallace KM, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source

Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales. [PDF]

Future Microbiol
Bhowmick T, Canton R, Pea F, Quevedo J, Santerre Henriksen A, Timsit JF, Kaye KS.   +6 more
europepmc   +1 more source

Are New β-Lactam/β-Lactamase Inhibitor Combinations Promising Against Carbapenem-Resistant K. pneumoniae Isolates? [PDF]

Pathogens
Ceylan AN, Kömeç S, Şanlı K, Öncel B, Durmuş MA, Gülmez A.   +5 more
europepmc   +1 more source

β-Lactam/β-Lactamase Inhibitor Combinations Non-Susceptible ESBL-Producing <i>Enterobacteriaceae</i> Bloodstream Infections: An Underestimated Clinical Entity. [PDF]

Infect Drug Resist
Zhang Y, Ni S, Hu H, Zhang S, Feng H, Ni L, Chen H, Yang Q, Yu M, Qu T.   +9 more
europepmc   +1 more source

Activity of β-Lactamase Inhibitor Combinations Against Enterobacterales Isolated from Patients with Intra-Abdominal Infection from United States Medical Centres (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Kimbrough JH, Winkler ML, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source

Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli. [PDF]

Microbiol Spectr
Kim TY, Baek JY, Suh E, Lee J-K, Yu H-J, Ko J-H, Huh HJ, Lee NY.   +7 more
europepmc   +1 more source

Characterization of GQA as a novel β-lactamase inhibitor of CTX-M-15 and KPC-2 enzymes. [PDF]

Microb Cell Fact
Al-Madboly LA, El-Salam MAA, Bastos JK, Aboukhatwa S, El-Morsi RM.   +4 more
europepmc   +1 more source